BNET Industries
Boston Scientific Corp. (BSX) is in the Health Care Industry
- Revenue
- Dec 31 2007
- $8.3B
- Profit
- Dec 31 2007
- ($495.0M)
- Market Cap
- Jul 22 2008
- $18.3B
Latest News and Analysis
Boston Scientific Corp. Q2 2008 Earnings Call Transcript
Boston Scientific Corporation BSX Q2 FY08 Earnings Call
Options Trader: Monday Outlook
Phil Davis submits: All right, nothing blew up this weekend and BAC had good earnings - looks like fun! Bank of America BAC beat by a mile with .72 in EARNINGS vs. .53 expected on revenues of $20Bn vs. $18Bn expected and, of course, miles and miles ahead...
Boston Scientific: Good Valuation, But Technically Shaky
Tate Dwinnell submits: The following post is provided exclusively to readers by the good folks at TheCorrectCall.com. I agree that medical and drug stocks are showing some resiliency... some even showing very bullish action, but being a technical trader myself, I personally would hold off on Boston Scientific BSX...
Boston Scientific Bundles Stents with Defibrillators and Ultrasound
Mike Huckman submits: FBR's Christopher Warren was out with a research note to clients Friday morning saying that Boston Scientific BSX is doing deals. He writes that BSX is "reportedly bundling $1,100 (that's right, $1,100) Taxus stents with defibrillators and ultrasound devices." Taxus is the name of Boston...
Boston Scientific Corp. Q1 2008 Earnings Call Transcript
Boston Scientific Corp. Q1 2008 Earnings Call Transcript
Boston Scientific Corp. Q1 2008 Earnings Call Transcript
Boston Scientific Corp. Q1 2008 Earnings Call Transcript
Boston Scientific Corp. Q4 2007 Earnings Call Transcript
Boston Scientific Corp. Q4 2007 Earnings Call Transcript
Boston Scientific Q3 2007 Earnings Call Transcript
Boston Scientific Q3 2007 Earnings Call Transcript
Boston Scientific Q2 2007 Earnings Call Transcript
Boston Scientific Q2 2007 Earnings Call Transcript
Bar Coding Helps Boston Scientific 'Error-Proof' Medical Device Packaging
Boston Scientific Corp., one of the world's largest manufacturers of medical devices, has implemented a new solution for automatically identifying its products prior to packaging. With bar code scanning and a vision inspection system, the company is able to assure that its balloon and stent delivery catheters are correctly packaged...
Additional Resources
Antisoma appoints Michael Lewis as a Non-Executive Director
9 July 2008 London, UK: Antisoma plc (LSE: ASM; USOTC: ATSMY) todayannounces the appointment of Mr Michael Lewis as a Non-ExecutiveDirector with immediate effect. Mr Lewis is currently President for Europe, Middle East and Africaand was also Head of Global Marketing for the medical device companyGambro, with responsibility for USD...
Joe Hallow Named to the Board of Directors of BridgePoint Medical, LLC
LEXINGTON, Ky., July 8 /PRNewswire/ -- BridgePoint Medical, LLC, an independently owned prosthetic and orthotic company, today announced that Joseph F. Hallow, III has been elected to serve on its Board of Directors. Mr. Hallow currently serves as president of Bissell Hotels in Charlotte, North Carolina. As president and...
Boston Scientific Announces FDA Approval for PROMUS™ Everolimus-Eluting Coronary Stent System
Boston Scientific only company to offer choice of two distinct drugs on separate drug-eluting stent platforms NATICK, Mass., July 2 /PRNewswire-FirstCall/ -- Boston Scientific Corporation today announced that the U.S. Food and Drug Administration FDA has approved the PROMUSTM Everolimus-Eluting Coronary Stent System for the treatment...
FDA Approves Abbott's XIENCE™ V Drug Eluting Stent
XIENCE V, Only Drug Eluting Stent to Demonstrate Superiority Over Market-Leading Stent in Clinical Trials, Now Available in United States for Treatment of Coronary Artery Disease ABBOTT PARK, Ill., July 2 /PRNewswire-FirstCall/ -- Abbott today announced that the U.S. Food and Drug Administration FDA approved the XIENCETM...
Boston Scientific To Webcast Conference Call Discussing Second Quarter Financial Results
NATICK, Mass., June 26 /PRNewswire-FirstCall/ -- Boston Scientific Corporation will webcast its conference call discussing financial results for the second quarter ended June 30, 2008 on Tuesday, July 22, at 8:30 a.m. ET. The call will be hosted by Jim Tobin, President and Chief Executive Officer,...
Maria Sainz Elected to Orthofix International Board of Directors
BOSTON -- Orthofix International N.V. (NASDAQ:OFIX) announced today that Maria Sainz has been elected to the company's Board of Directors. Ms. Sainz currently serves as the President and CEO of Concentric Medical. Prior to joining Concentric Medical she was President of Guidant Corporation's Cardiac Surgery Division, and a...
Boston Scientific Welcomes Progress on Pain Care Legislation
NATICK, Mass., June 23 /PRNewswire-FirstCall/ -- Boston Scientific Corporation today welcomed progress on a number of pieces of legislation that will help service veterans and the active armed forces better manage the challenges of chronic pain. The U.S. Senate has recently passed the Veterans Mental Health Improvements...
Saints Capital to Acquire Interests in Fifty-Four Companies From Boston Scientific Corporation
Saints Capital, a leading secondarydirect investment firm, today announced that it has signed a definitiveagreement to acquire interests in fifty-four companies from BostonScientific Corporation, (NYSE: BSX), a worldwide developer, manufacturerand marketer of medical devices. "Boston Scientific has made a number of investments in high qualitycompanies and we are excited...
Boston Scientific Announces Agreements to Sell Non-Strategic Investments
Transactions further Company's plans to focus on core businesses and increase shareholder value NATICK, Mass., June 19 /PRNewswire-FirstCall/ -- Boston Scientific Corporation today announced that it has signed a definitive agreement to sell its investments in a portfolio of companies, subject to certain closing and other...
Swedish medical systems provider Getinge AB relocates manufacture of cardiac surgery products from Puerto Rico to New Jersey
NORDIC BUSINESS REPORT-18 June 2008-Swedish medical systems provider Getinge AB relocates manufacture of cardiac surgery products from Puerto Rico to New JerseyC1994-2008 M2 COMMUNICATIONS LTD http://www.m2.com Swedish medical systems provider Getinge AB (OMX Stockholm: GETI B) announced on Wednesday (18 June) that its business area Medical Systems has...
- Next »
- page 1 of 78
- « Previous
Sort byClose
- Incorporated: 1979
- CEO: Mr. James R. Tobin
Boston Scientific is a developer, manufacturer and marketer of medical devices that are used in a variety of interventional medical specialties including interventional cardiology, cardiac rhythm management, peripheral interventions, electrophysiology, neurovascular intervention, oncology, endoscopy, urology, gynecology and neuromodulation. Co.'s products are offered for sale mainly by three business groups: Cardiovascular, which includes its interventional cardiology, cardiac rhythm management and cardiovascular divisions; Endosurgery, which includes its oncology, endoscopy and urology/gynecology divisions; and Neuromodulation, which includes its auditory and pain management divisions.
Key Competitors
Boston Scientific Corp. Company Info
Board of Directors
Mr. Peter M. Nicholas
Chairman
Mr. James R. Tobin
Mr. John E. Abele
Mr. Joel L. Fleishman
Dr. Kristina M. Johnson Ph.D.
Dr. Ernest Mario Ph.D.
Dr. Uwe E. Reinhardt
Ms. Ursula M. Burns
Ms. Nancy-Ann DeParle
Mr. J. Raymond Elliott
Dr. Marye Anne Fox Ph.D.
Mr. Ray J. Groves
Mr. N. J. Nicholas Jr.
Mr. John E. Pepper Jr.
Senator Warren B. Rudman
Contact Information
One Boston Scientific Place
Natick, MA
508 650-8000
